Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 32, 2018 - Issue 4
242
Views
12
CrossRef citations to date
0
Altmetric
Review Articles

A brief review of potent anti-CNS tumourics from marine sponges: covering the period from 1994 to 2014

&
Pages 375-384 | Received 18 Dec 2016, Accepted 16 Mar 2017, Published online: 07 Apr 2017

References

  • Biegelmeyer R, Schröder R, Rambo DF, Dresch RR, Carraro JLF, Mothes BB, Moreira JC, da Frota Junior ML, Henriques AT. 2016. pH-dependent cytotoxic effects of extracts of the marine sponge Polymastia janeirensis on cancer cell lines. Nat Prod Res. 30:2734–2737.10.1080/14786419.2016.1143824
  • Blunt JW, Copp BR, Munro MHG, Northcote PT, Prinsep MR. 2003. Marine natural products. Nat Prod Rep. 20:1–48.10.1039/b207130b
  • Blunt JW, Copp BR, Hu WP, Munro MHG, Northcote PT, Prinsep MR. 2009. Marine natural products. Nat Prod Rep. 26:170–244.10.1039/b805113p
  • Blunt JW, Copp BR, Munro MHG, Northcote PT, Prinsep MR. 2010. Marine natural products. Nat Prod Rep. 27:165–237.10.1039/b906091j
  • Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR. 2014. Marine natural products. Nat Prod Rep. 31:160–258.10.1039/c3np70117d
  • Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR. 2016. Marine natural products. Nat Prod Rep. 33:382–431.10.1039/C5NP00156K
  • Bugni TS, Ireland CM. 2004. Marine-derived fungi: a chemically and biologically diverse group of microorganisms. Nat Prod Rep. 21:143–163.10.1039/b301926h
  • Costantini AS, Gallo F, Pega F, Saracci R, Veerus P, West R. 2015. Population health and status of epidemiology in Western European, Balkan and Baltic countries. Int J Epi. 44:300–323.10.1093/ije/dyu256
  • Dionisi HM, Lozada M, Olivera NL. 2012. Bioprospection of marine microorganisms: biotechnological applications and methods. Rev Argent Microbiol. 44:49–60.
  • Fan WY, Wang ZL, Li HC, Fossey JS, Deng WP. 2011. A straightforward and efficient synthetic access to biologically active marine sesterterpenoids, sesterstatins 4 and 5. Chem Commun. 47:2961–2963.10.1039/c0cc04857g
  • Faulkner DJ. 1996. Marine natural products. Nat Prod Rep. 13:75–125.10.1039/np9961300075
  • Faulkner DJ. 2000. Marine natural products. Nat Prod Rep. 17:7–55.10.1039/a809395d
  • Faulkner DJ. 2001. Marine natural products. Nat Prod Rep. 18:1–49.10.1039/b006897g
  • Graham PL. 2001. An introduction to medicinal chemistry. New York, NY: Oxford University Press.
  • Haefner B. 2003. Drugs from the deep: marine natural products as drug candidates. Drug Discov Today. 8:536–544.10.1016/S1359-6446(03)02713-2
  • He W-J, Zhou X-J, Qin X-C, Mai Y-X, Lin X-P, Liao S-R, Yang B, Zhang T, Tu ZC, Wang JF, Liu Y. 2017. Quinone/hydroquinone meroterpenoids with antitubercular and cytotoxic activities produced by the sponge-derived fungus Gliomastix sp. ZSDS1-F7. Nat Prod Res. 31:604–609.10.1080/14786419.2016.1207076
  • Jimenez MS, Garzón SP, Rodríguez AD. 2003. Plakortides M and N, bioactive polyketide endoperoxides from the Caribbean marine sponge Plakortis halichondrioides. J Nat Prod. 66:655–661.10.1021/np030021h
  • Louis DN, Perry A, Reifenberger G, von Deimling AV, Figarella Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. 2016. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131:803–820.10.1007/s00401-016-1545-1
  • Mayer AMS. 1999. Marine pharmacology in 1998: Antitumor and cytotoxic compounds. The Pharmacologist. 41:159–164.
  • Mayer AMS, Gustafson KR. 2006. Marine pharmacology in 2003–2004: anti–tumour and cytotoxic compounds. Euro J Can. 42:2241–2270.10.1016/j.ejca.2006.05.019
  • Mehbub MF, Perkins MV, Zhang W, Franco CMM. 2016. New marine natural products from sponges (Porifera) of the order Dictyoceratida (2001 to 2012); a promising source for drug discovery, exploration and future prospects. Biotech Adv. 34:473–491.10.1016/j.biotechadv.2015.12.008
  • Mollica A, Stefanucci A, Feliciani F, Lucente G, Pinnen F. 2011. Synthesis of (S)-5,6-dibromo-tryptophan derivatives as building blocks for peptide chemistry. Tetrahedron Lett. 52:2583–2585.10.1016/j.tetlet.2011.03.041
  • Mollica A, Locatelli M, Stefanucci A, Pinnen F. 2012. Synthesis and bioactivity of secondary metabolites from marine sponges containing dibrominated indolic systems. Molecules. 17:6083–6099.10.3390/molecules17056083
  • Mostafa ER, Rainer E. 2011. Secondary metabolites of fungi from marine habitats. Nat Prod Rep. 28:290–344.
  • Müller WEG, Zahn RK, Eich E, inventors and assignee. 1992 Jan 21. Avarol and its production and use as an antitumor agent (I). United States patent US 5,082,865
  • Pejin B, Iodice C, Tommonaro G, De Rosa S. 2008. Synthesis and biological activities ofthio-avarol derivatives. J Nat Prod. 71:1850–1853.10.1021/np800318m
  • Pejin B, Vitale RM, Tommonaro G, Iodice C, De Rosa S, Amodeo P. 2011. Development of semisynthetic inhibitors of acetylcholinesterase (AChE) as potential anti-Alzheimer drugs by an integrated computational-experimental approach Science and Supercomputing in Europe: Research Highlights in 2011 (DG Research in the Seventh Framework Programme - FP7, p 93).
  • Pejin B, Jovanovic KK, Mojovic M, Savic AG. 2013. New and highly potent antitumor natural products from marine-derived fungi: covering the period from 2003 to 2012. Curr Top Med Chem. 13:2745–2766.10.2174/15680266113136660197
  • Pejin B, Mojović M, Savić AG. 2013b. Novel antitumour natural products from the phylum Bryozoa. Biol Serb. 35:3–14.
  • Pejin B, Iodice C, Tommonaro G, Bogdanovic G, Kojic V, De Rosa S. 2014a. Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4’-leucine-avarone. Nat Prod Res. 28:347–350.10.1080/14786419.2013.863201
  • Pejin B, Iodice C, Tommonaro G, Stanimirovic B, Ciric A, Glamoclija J, Nikolic M, Rosa S, Sokovic M. 2014b. Further in vitro evaluation of antimicrobial activity of the marine sesquiterpene hydroquinone avarol. Curr Pharm Biotechnol. 15:583–588.10.2174/138920101506140910152253
  • Pejin B, Jovanovic KK, Savic AG. 2015. New antitumour natural products from marine red algae: covering the period from 2003 to 2012. Mini Rev Med Chem. 15:720–730.10.2174/1389557515666150511152251
  • Pejin B, Ciric A, Markovic D, Tommonaro G, Sokovic M. 2016. In vitro avarol does affect the growth of Candida sp. Nat Prod Res. 30:1956–1960.10.1080/14786419.2015.1091454
  • Pettit GR, McNulty J, Herald DL, Doubek DL, Chapuis JC, Schmidt JM, Tackett LP, Boyd MR. 1997. Antineoplastic agents. 362. Isolation and X–ray crystal structure of dibromophakellstatin from the Indian Ocean sponge Phakellia mauritiana. J Nat Prod. 60:180–183.10.1021/np9606106
  • Pettit GR, Tan R, Melody N, Cichacz ZA, Herald DL, Hoard MS, Pettit RK, Chapuis JC. 1998. Antineoplastic agents 397: Isolation and structure of sesterstatins 4 and 5 from hyrtios erecta (the republic of maldives). Bio & Med Chem L. 8:2093–2098.10.1016/S0960-894X(98)00373-4
  • Pettit GR, Tan R, Cichacz ZA. 2005. Antineoplastic agents. 542. The isolation and structure of sesterstatin 6 from the Indian Ocean sponge Hyrtios erecta. J Nat Prod. 68:1253–1255.10.1021/np0402221
  • Pettit GR, Tang Y, Zhang Q, Bourne GT, Arm CA, Leet JE, Knight JC, Pettit RK, Chapuis JC, Doubek DL, Ward FJ, Weber C, Hooper JNA. 2013. Isolation and structures of axistatins 1−3 from the Republic of Palau marine sponge Agelas axifera Hentschel. J Nat Prod. 76:420–424.10.1021/np300828y
  • de Rosa S, Tommonaro G. 2012. Bioactive marine prenylated quinones/quinols. In: Atta-ur-Rahman. editor. Studies in Natural Products Chemistry: Bioactive Natural Products (Part P). Oxford: Elsevier B.V.; p. 163–218.
  • Saleem M, Ali MS, Hussain S, Jabbar A, Ashraf M, Lee YS. 2007. Marine natural products of fungal origin. Nat Prod Rep. 24:1142–1152.10.1039/b607254m
  • Sarin H. 2009. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Trans Med. 7:1–14.
  • Shaala LA, Youssef DTA, Ibrahim SRM, Mohamed GA. 2016. Callyptide A, a new cytotoxic peptide from the Red Sea marine sponge Callyspongia species. Nat Prod Res. 30:2783–2790.10.1080/14786419.2016.1155577
  • Shahpar S, Mhatre PV, Huang ME. 2016. Update on brain tumors: new developments in neuro–oncologic diagnosis and treatment, and impact on rehabilitation strategies. PM&R. 8:678–689.
  • Shinde PB, Mansoor TA, Luo X, Hong J, Lee CO, Jung JH. 2007. Cytotoxic polyketides from the marine sponge Discodermia calyx. Bull Korean Chem Soc. 28:990–994.
  • Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH. 2005. Marine natural products as anticancer drugs. Mol Cancer Ther. 4:333–342.
  • Tommonaro G, Pejin B, Iodice C, Tafuto A, De Rosa S. 2015. Further in vitro biological activity evaluation of amino-, thio- and ester- derivatives of avarol. J Enzyme Inhib Med Chem. 30:333–335.10.3109/14756366.2014.913037
  • Tommonaro G, García-Font N, Vitale RM, Pejin B, Iodice C, Cañadas S, Marco Contelles J, Oset-Gasque MJ. 2016. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer’s disease. Eur J Med Chem. 122:326–338.10.1016/j.ejmech.2016.06.036
  • Wang J-F, Qin X, Xu F-Q, Zhang T, Liao S, Lin X. 2015. Tetramic acid derivatives and polyphenols from sponge-derived fungus and their biological evaluation. Nat Prod Res. 29:1761–1765.10.1080/14786419.2014.999061
  • Wang Y-T, Xue Y-R, Liu C-H. 2015. A brief review of bioactive metabolites from deep-sea fungi. Mar Drugs. 13:4594–4616.10.3390/md13084594
  • Xiong Z-Q, Wang J-F, Hao Y-Y, Wang Y. 2013. Recent advances in the discovery and development of marine microbial natural products. Mar Drugs. 11:700–717.10.3390/md11030700
  • Zhang H, Loveridge ST, Tenney K, Crews P. 2016. A new 3-alkylpyridine alkaloid from the marine sponge Haliclona sp. and its cytotoxic activity. Nat Prod Res. 30:1262–1265.10.1080/14786419.2015.1054826
  • Zhang H, Dong M, Wang H, Crews P. 2017. Secondary metabolites from the marine sponge genus Phyllospongia. Mar Drugs. 15:12. doi:10.3390/md15010012.
  • Zöllinger M, Kelter G, Fiebig HH, Lindel T. 2007. Antitumor activity of the marine natural product dibromophakellstatin in vitro. Bioorg Med Chem Lett. 17:346–349.10.1016/j.bmcl.2006.10.046

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.